STRO
Sutro Biopharma
15.40$
-3.9%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | -560.1% | – | -782.3% | – | – | – | – | – | – | – | – | |
| – | -0.5% | +1.7% | +1.6% | +0.5% | +3.8% | +1.7% | +0.0% | +0.0% | -14.5% | -21.3% | -1.3% | – | |
| – | +3.7% | -2.5% | +1.5% | +6.3% | -9.6% | -6.4% | -5.0% | -70.5% | +6.6% | -5.6% | +28.7% | – | |
| – | -676.7% | – | – | -114.7% | – | – | – | – | +0.6% | -462.1% | – | – | |
| – | +339.3% | -69.0% | +69.5% | +9.5% | +29.0% | +9.9% | -92.7% | +191.9% | -26.7% | -94.0% | -100.0% | – | |
| – | -79.4% | – | -225.4% | – | -40.6% | -118.6% | – | +1,450.0% | -53.2% | -342.0% | – | – | |
| – | – | -176.3% | -90.1% | – | -106.4% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -45.6% | +9.7% | – | -98.9% | -102.4% | – | -190.9% | – | -162.7% | – | -100.4% | – | |
| – | – | – | – | +227.7% | -81.2% | -634.6% | – | – | -509.9% | – | -224.4% | – | |
| – | – | -616.1% | – | -851.2% | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.